Personalized Medicine Production Started with 3D Printer

The vast majority of drugs sold in pharmacies today are mass production product. In fact, this is a necessary thing because drugs have to be produced in large quantities in order to be sold cheaply, otherwise their prices will increase considerably.

What about drugs available on the market? what if you need a different dose? Since the drug you want to buy comes from mass production in a single dose, you have to pay much more money for the drug you want to obtain, or you may not even be able to find it. At this point, personalized medicines come into play.

Thanks to the work of this Finland-based company, medicines will be custom-made with 3D printers:

An initiative called CurifyLabs, headquartered in Helsinki, Finland, has started the production of personalized medicines using 3D printers. The aim of the company is to bring this technology to hospitals and veterinary clinics in the first place.

The company, which was founded last year and started the project with a capital of 3.5 million euros; thus aiming to meet the exact needs of a patient:

Under normal conditions, a drug that comes off the mass production line is not personal and at this point, it is not possible to talk about a completely appropriate treatment. For example, it is impossible to remove an allergen substance from a mass-produced drug, but it is possible with personalized drug treatments.

The first prototype work at CurifyLabs also begins with the curiosity of founder Niklas Sandler Topelius:

In fact, Topelius, a scientist who has published scientific articles in more than 100 approved journals, places drug materials in appropriate forms and shapes in the “ink” section of an ordinary three-dimensional printer for the first prototype, and the first results are remarkable. The company, which then received an investment of 3.5 million euros on this concept, is now working on developing special printer technologies for this business.

Although the company has a market value of 3.5 million euros, the total volume of the global healthcare industry is 1.42 trillion dollars, so the company is still at the beginning:

If this project of CurifyLabs branches out further in the future, we can say goodbye to traditional pharmacies and all of us can produce personalized medicines and we can be treated in a much healthier way than mass-produced drugs. What are you thinking? Please do not forget to share your thoughts with us in the comments.